Updated:
Dubai AI policy: what hospitals must do once AI is live
Dubai's AI policy sets duties for end users: designated overrides, incident reports to DHA and independent audits. What the text says, in plain words.
A radiology tool is live, an alert looks wrong at 3 a.m., and the charge nurse asks who is allowed to overrule it and who must be told. Dubai’s health regulator answers these questions in its AI policy, in a section aimed at “end users” such as hospitals and clinics. This post reads only that policy document, the Dubai Health Authority (DHA) policy “Artificial Intelligence in the Healthcare” (reference DHA/HISHD/PP-09). It is general information, not legal advice, and other Dubai or federal rules may apply too.
Who the policy speaks to
The document lists duties for several groups. Section 4.8 is headed “End users of AI solutions in the Emirate of Dubai must”, and it is the part most relevant to a hospital that has bought an AI tool. The policy’s header shows an issue date of 1 July 2021 and an effective date of 1 October 2021. It also shows a revision date of 1 July 2026, so check with DHA whether a newer version exists before relying on this summary.
Overrides and appeals
Two design requirements matter for daily work. Section 4.4.2 says AI solutions that may directly affect people’s lives in a significant way must be designed with utmost care, and must be able to be overridden, or their decisions reversed, by designated end users. Section 4.2.3 says AI solutions must have built-in appeals procedures so that users can challenge significant decisions. In practice, “designated” suggests the hospital should decide in advance who holds the override, rather than leaving it to whoever is on shift.
Watching the tool in real use
Section 4.6.11 says the performance of an AI tool must be monitored in clinical practice, and that actual outcomes must be compared with those obtained in training and validation. Any significant discrepancy must call for further inspection. Section 4.6.13 adds that the tool must be equipped with “graceful degradation” mechanisms, meaning automatic alerts and gradual operation cessation. These sit in the part of the policy addressed to the tool, so ask the vendor to show you how each one works.
What end users must do
Under section 4.8, end users must:
- report to DHA’s Health Regulation Sector all known or suspected incidents or deficiencies related to AI solutions used in their facility (4.8.1), and any implementation issues that could affect patient safety (4.8.2);
- give clear guidelines and boundaries on access to and sharing of patient information (4.8.3);
- make sure everyone involved, including patients, receives education on AI and its effective use (4.8.4);
- conduct regular audits of AI functionality by an independent third party, reporting to DHA as needed (4.8.5);
- submit end-user feedback to DHA and to the manufacturing company (4.8.6).
The policy gives no deadline for incident reports in the sections we read. Do not borrow a number from another emirate or country.
A one-page checklist for a ward
These are our suggestions drawn from the policy, not requirements it states.
- Name the person who may override the AI, and write down how.
- Put a “who do we tell” line on the unit card: your internal safety lead, who then decides on the report to DHA.
- Schedule an independent audit and note who pays for it.
- Keep a short record of staff and patient education on the tool.
Key takeaways
- Dubai’s AI policy expects designated end users to be able to override or reverse significant AI decisions, with built-in appeals (sections 4.4.2 and 4.2.3).
- End users must report AI incidents and patient-safety issues to DHA, arrange regular independent audits and educate staff and patients (section 4.8).
- The policy’s revision date was 1 July 2026, so check the current version with DHA. This is general information, not legal advice.
Source: Dubai Health Authority, Artificial Intelligence in the Healthcare, DHA/HISHD/PP-09, sections 4.2.3, 4.4.2, 4.6.11, 4.6.13 and 4.8. Read on 16 November 2026.
This site’s content is for general information, research, and education. It does not replace medical diagnosis or advice for any specific patient, and it is not legal advice.